16 results
8-K
EX-99.3
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
for patients with limited treatment options and poor outcomes. Elicio’s scientific advisors offer expert technical guidance to help shape Elicio’s scientific
DEF 14A
ELTX
Elicio Therapeutics Inc.
27 Apr 22
Definitive proxy
4:04pm
is an audit committee financial expert as defined under the applicable rules of the SEC and has the requisite financial sophistication as defined under
10-K
pixk543 qoiz3
30 Mar 21
Annual report
5:00pm
424B4
d5grn28f850 80
5 Feb 21
Prospectus supplement with pricing info
5:12pm
CORRESP
noxn7l4c9wt fzb41ik
26 Jan 21
Correspondence with SEC
12:00am
DRS/A
9andka0os2civ
15 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
vpgmh62ym lz
13 May 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next